U.S. markets closed

Vyant Bio, Inc. (VYNT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.95000.0000 (0.00%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/27/2021
Current
Market Cap (intraday) 5
85.80M
Enterprise Value 3
54.08M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
98.96
Price/Book (mrq)
1.34
Enterprise Value/Revenue 3
62.38
Enterprise Value/EBITDA 7
-7.72

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 30.34%
S&P500 52-Week Change 333.41%
52 Week High 317.5000
52 Week Low 32.1100
50-Day Moving Average 33.5011
200-Day Moving Average 34.2677

Share Statistics

Avg Vol (3 month) 3493.89k
Avg Vol (10 day) 3129.5k
Shares Outstanding 528.99M
Implied Shares Outstanding 6N/A
Float 26.47M
% Held by Insiders 17.57%
% Held by Institutions 14.89%
Shares Short (Jul 14, 2021) 4252.73k
Short Ratio (Jul 14, 2021) 41.01
Short % of Float (Jul 14, 2021) 4N/A
Short % of Shares Outstanding (Jul 14, 2021) 40.87%
Shares Short (prior month Jun 14, 2021) 4684.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 24, 2019
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-706.84%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)921k
Revenue Per Share (ttm)0.34
Quarterly Revenue Growth (yoy)32.10%
Gross Profit (ttm)-234k
EBITDA -5.96M
Net Income Avi to Common (ttm)-14.04M
Diluted EPS (ttm)-5.2660
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)33.07M
Total Cash Per Share (mrq)1.14
Total Debt (mrq)1.36M
Total Debt/Equity (mrq)2.12
Current Ratio (mrq)4.69
Book Value Per Share (mrq)2.20

Cash Flow Statement

Operating Cash Flow (ttm)-8.86M
Levered Free Cash Flow (ttm)N/A